Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 2958-2965

  Koizumi, Y ^a   Kurita Ochiai, T ^a   Oguchi, S ^a   Yamamoto, M ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 8; OUTER MEMBRANE PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CYTOKINE; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; BACTERIAL STRAIN; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE AMPLIFICATION; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MORPHOMETRICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROPHYLAXIS; ANIMAL; ATHEROSCLEROSIS; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; METABOLISM; PATHOGENICITY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CHOLERA TOXIN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNIZATION; INFLAMMATION; MICE; MICE, INBRED BALB C; PORPHYROMONAS GINGIVALIS;

EID: 46449118636     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01572-07     Document Type: Article

References (55)

1. Abiko, Y., N. Ogura, U. Matsuda, K. Yanagi, and H. Takiguchi. 1997. A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis. Infect. Immun. 65:3966-3969.
2. Aggerbeck, H., S. Gizurarson, J. Wantzin, and I. Heron. 1997. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 15:307-316.
3. Amar, S., N. Gokce, S. Morgan, M. Loukideli, T. E. Van Dyke, and J. A. Vita. 2003. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 23: 1245-1249.
4. Anonymous. 1996. Consensus report. Periodontal diseases: pathogenesis and microbial factors. Ann. Periodontol. 1:926-932.
5. Apostolopoulos, J., P. Davenport, and P. G. Tipping. 1996. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler. Thromb. Vasc. Biol. 16:1007-1012.
6. Ashimoto, A., C. Chen, I. Bakker, and J. Slots. 1996. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol. Immunol. 11:266-273.
7. Beck, J. D., J. R. Elter, G. Heiss, D. Couper, S. M. Mauriello, and S. Offenbacher. 2001. Relationship of periodontal disease to carotid artery intima-media wall thickness: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler. Thromb. Vasc. Biol. 21:1816-1822.
8. Boisvert, W. A., R. Santiago, L. K. Curtiss, and R. A. Terkeltaub. 1998. A leukocyte homologue of the IL-8 receptor CXCR2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Investig. 101:353-363.
9. Brodala, N., E. P. Merricks, D. A. Bellinger, D. Damrongsri, S. Offenbacher, J. Beck, P. Madianos, D. Sotres, Y. L. Chang, G. Koch, and T. C. Nichols. 2005. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesteromic pigs. Arterioscler. Thromb. Vasc. Biol. 25:1446-1451.
10. Chi, H., E. Messas, R. A. Levine, D. T. Graves, and S. Amar. 2004. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 110:1678-1685.
11. Chou, H., H. Yumoto, M. Davey, Y. Takahashi, T. Miyamoto, F. C. Gibson III, and C. A. Genco. 2005. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect. Immun. 73:5367-5378.
12. Ford, P. J., E. Gemmell, P. Timms, A. Chan, F. M. Preston, and G. J. Seymour. 2007. Anti-P. gingivalis response correlates with atherosclerosis. J. Dent. Res. 1:35-10.
13. Galkina, E., A. Kadl, J. Sanders, D. Varughese, I. J. Sarembock, and K. Ley. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203:1273-1282.
14. Giacona, M. B., P. N. Papapanou, I. B. Lamster, L. L. Rong, V. D. Agati, A. M. Schmidt, and E. Lalla. 2004. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS. Microbiol. Lett. 241:95-101.
15. Gibson, F. C., III, H. Yumoto, Y. Takahashi, H. H. Chou, and C. A. Genco. 2006. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 85:106-121.
16. Gluck, U., J. O. Gebbers, and R. Gluck. 1999. Phase I evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers. J. Virol. 73:7780-7786.
17. Haghighat, A., D. Weiss, M. K. Whalm, D. P. Cowan, and W. R. Taylor. 2007. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115:2049-2054.
18. Haraszthy, V. I., J. J. Zambon, M. Trevisan, M. Zeid, and R. J. Genco. 2000. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71:1554-1560.
19. Herzberg, M. C., and M. W. Weyer. 1998. Dental plaque, platelets, and cardiovascular diseases. Ann. Periodontol. 3:151-160.
20. Hiratsuka, K., W. Yoshida, M. Hayakawa, H. Takiguchi, and Y. Abiko. 1996. Polymerase chain reaction and an outer membrane protein gene probe for the detection of Porphyromonas gingivalis. FEMS. Microbiol. Lett. 138:167-172.
21. Hiratsuka, K., Y. Abiko, M. Hayakawa, T. Ito, H. Sasahara, and H. Takiguchi. 1992. Role of Porphyromonas gingivalis 40-kDa outer membrane protein in the aggregation of P. gingivalis vesicles and Actinomyces viscosus. Arch. Oral Biol. 37:717-724.
22. Hujoel, P. P., M. Drangsholt, C. Spiekerman, and T. A. DeRouen. 2000. Periodontal disease and coronary heart disease risk. JAMA 284:1406-1410.
23. Kawamoto, Y., M. Hayakawa, and Y. Abiko. 1991. Purification and immunochemical characterization of a recombinant outer membrane protein from Bacteroides gingivalis. Int. J. Biochem. 23:1053-1061.
24. Koizumi, Y., T. Kurita-Ochiai, and M. Yamamoto. 2008. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses. Oral Microbiol. Immunol. 23:131-138.
25. Kozarov, E. V., B. R. Dorn, C. E. Shelburne, W. A. Dunn, Jr., and A. Progulske-Fox. 2005. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25:17-18.
26. Lalla, E., I. B. Lamster, M. A. Hofmann, L. Bucciarelli, A. P. Jerud, S. Tucker, Y. Lu, P. N. Papapanou, and A. M. Schmidt. 2003. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 23:1405-1411.
27. Libby, P. 2000. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am. J. Cardiol. 86:3J-9J.
28. Libby, P. 2002. Inflammation in atherosclerosis. Nature 420:868-874.
29. Li, F., S. M. Michalek, A. P. Dasanayake, Y. Li, K. Kirk, and N. K. Childers. 2003. Intranasal immunization of humans with Streptococcus mutans antigens. Oral Microbiol. Immunol. 18:271-277.
30. Li, L., E. Messas, E. L. Batista, L. A. Levine, and S. Amar. 2002. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105:861-867.
31. Madan, M., B. Bishayi, M. Hoge, and S. Amar. 2008. Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model. Atherosclerosis 197:504-514.
32. Matsushima, Y., S. Hayashi, and M. Tachibana. 1999. Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency. Mamm. Genome 10:352-357.
33. Matsushima, Y., T. Sakurai, A. Ohoka, T. Ohnuki, N. Tada, Y. Asoh, and M. Tachibana. 2001. Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J. Atheroscler. Thromb. 8:71-79.
34. McGhee, J. R., and H. Kiyono. 1999. The mucosal immune system, p. 909-930. In W. E. Paul (ed.), Fundamental immunology. Lippincott-Raven Publishers, Philadelphia, PA.
35. Namikoshi, J., S. Otake, S. Maeba, M. Hayakawa, Y. Abiko, and M. Yamamoto. 2003. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis. Vaccine 22:250-256.
36. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68:231-240.
37. Papapanou, P. N. 1996. Periodontal diseases: epidemiology. Ann. Periodontol. 1:1-36.
38. Pussinen, P. J., P. Jousilahti, G. Alfthan, T. Palosuo, S. Asikainen, and V. Salomaa. 2003. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 23:1250-1254.
39. Qi, M., H. Miyakawa, and H. K. Kuramitsu. 2003. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb. Pathog. 35:259-267.
40. Ridker, P. M. 2002. On evolutionary biology, inflammation, infection, and the cause of atherosclerosis. Circulation 105:2-4.
41. Ridker, P. M., M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens. 1997. Inflammation, aspirin, and the risk of future myocarditis infarction among apparently healthy men. N. Engl. J. Med. 336:973-979.
42. Ridker, P. M., N. Rifai, M. J. Stampfer, and C. H. Hennekens. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772.
43. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115-126.
44. Ross, R. 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138:S419-S420.
45. Rothenbacher, D., S. Muller-Scholge, C. Herder, W. Koening, and H. Kolb. 2006. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler. Thromb. Vasc. Biol. 26:194-199.
46. Saito, S., K. Hiratsuka, M. Hayakawa, H. Takiguchi, and Y. Abiko. 1997. Inhibition of a Porphyromonas gingivalis colonizing factor between Actinomyces viscosus ATCC 19246 by monoclonal antibodies against recombinant 40-kDa outer-membrane protein. Gen. Pharmacol. 28:675-680.
47. Scannaperco, F. A., R. B. Bush, and S. Paju. 2003. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke: a systemic review. Ann. Periodontol 8:38-53.
48. Shibata, Y., K. Hiratsuka, M. Hayakawa, T. Shiroza, H. Takiguchi, Y. Nagatsuka, and Y. Abiko. 2003. A 35-kDa co-aggregation factor is a hemin binding protein in Porphyromonas gingivalis. Biochem. Biophys. Res. Commun. 300:351-356.
49. Tellides, G., D. A. Tereb, N. C. Kirkiles-Smith, R. W. Kim, J. H. Wilson, J. S. Schechner, M. I. Lorber, and J. S. Pober. 2000. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403:207-211.
50. Tonetti, M. S., F. D'Aiuto, L. Nibali, A. Donald, C. Storry, M. Parkar, J. Suvan, A. D. Hingorani, P. Vallance, and J. Deanfield. 2007. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 356:911-920.
51. Vita, J. A., and J. Loscalzo. 2002. Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 106:164-166.
52. Vogel, S. N., L. L. Weedon, R. N. Moore, and D. L. Rosenstreich. 1982. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. II. T-cell modulation of macrophage sensitivity to LPS in vitro. Immunobiology 160:479-493.
53. Von der Thusen, J. H., J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen. 2003. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol. Rev. 55:133-166.
54. Wu, H., S. Ghosh, X. D. Perrard, L. Feng, G. E. Garcia, J. L. Perrard, J. F. Sweeney, L. E. Peterson, L. Chan, C. W. Smith, and C. M. Ballantyne. 2007. T-cell accumulation and regulated on activation, normal T-cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115:1029-1038.
55. Wu, T., M. Trevisan, R. J. Genco, J. P. Dorn, K. L. Falkner, and C. T. Sempos. 2000. Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch. Intern. Med. 160:2749-2755.